Pulmonary Tuberculosis

General Medicine

Chronic granulomatous infection by Mycobacterium tuberculosis, primarily affecting lungs.

History taking

  • Cough >2 weeks, evening rise of temperature, night sweats, weight loss
  • Haemoptysis, anorexia, chest pain
  • TB contact, HIV status, prior TB treatment (RIPE)
  • Diabetes, steroids, alcohol, smoking

Examination

  • Cachexia, clubbing, lymphadenopathy
  • Chest: bronchial breathing, crackles in upper zones; signs of effusion/fibrosis

Red flags

  • Massive haemoptysis, respiratory failure
  • Meningitis, miliary TB, spinal TB (Pott's) with cord compression
  • MDR/XDR TB

Differential diagnosis

  • Bacterial pneumonia, lung abscess, fungal infections
  • Lung malignancy, sarcoidosis, bronchiectasis

Recommended investigations

  • Sputum CBNAAT (GeneXpert) — first test (also detects rifampicin resistance)
  • Sputum AFB smear x2, MGIT culture & DST
  • Chest X-ray (upper-lobe cavities, fibrosis)
  • HIV test, blood sugar, LFT, RFT before therapy

Diagnosis

  • Microbiological confirmation preferred (CBNAAT or culture)
  • Clinically diagnosed TB allowed if strong evidence + initiate therapy

Initial treatment / management

  • Standard regimen: 2 months HRZE + 4 months HR (DS-TB)
  • Weight-banded fixed-dose combinations per NTEP
  • Pyridoxine 10 mg OD with INH
  • Notify under NIKSHAY; nutritional support

Prescription examples

  • Tab HRZE (FDC, weight-band) PO OD empty stomach x 2 months (intensive phase)
  • Tab HR (FDC) PO OD x 4 months (continuation)
  • Tab Pyridoxine 10 mg PO OD throughout therapy

Follow-up advice

  • Symptom & weight review monthly; sputum AFB at end of 2 months and 5 months
  • Baseline + monthly LFT (especially if alcohol/HBV)
  • Vision/colour vision check during ethambutol use

Patient counselling

  • Adherence is curative; cough hygiene; isolation until sputum-negative
  • Family screening (contacts <6 y get IPT)
  • Avoid alcohol; nutrition support; HIV testing

Referral criteria

  • Drug resistance (Rif-R on CBNAAT), MDR/XDR
  • Extrapulmonary TB (CNS, spine, miliary)
  • Severe hepatotoxicity, paradoxical reaction

Clinical pearls

  • Three negative smears do not exclude TB — always do CBNAAT in suspects
  • Always test for HIV in TB patients
  • Hepatitis on RIPE: stop all, restart sequentially after LFT normalises

References

  • WHO Consolidated Guidelines on TB 2023
  • NTEP Technical and Operational Guidelines 2023 (India)

Educational outpatient guide — verify against local guidelines before clinical use.

WardRound

WardRound

Clinical Decisions in Seconds